Stay updated on Enapotamab Vedotin Safety Study in Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the Enapotamab Vedotin Safety Study in Solid Tumors Clinical Trial page.

Latest updates to the Enapotamab Vedotin Safety Study in Solid Tumors Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedRevision: v3.4.2 replaces v3.4.1; no substantive changes to the study page content are evident.SummaryDifference0.0%

- Check20 days agoChange DetectedRevision: v3.4.1 added and v3.4.0 removed on the site; no impact on study details or documents. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check27 days agoChange DetectedAdded a Show glossary option and updated QC-related metadata to 'Last Update Submitted that Met QC Criteria' and 'Revision: v3.4.0'. Removed the older QC label, No FEAR Act data, and 'Revision: v3.3.4'.SummaryDifference0.1%

- Check42 days agoChange DetectedRevision updated from v3.3.3 to v3.3.4. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check63 days agoChange DetectedIntroduced a centralized Locations section listing participating sites by region (including US states and Flemish Brabant) and removed the separate per-location 'Locations' subpages in favor of the consolidated section; Revision updated from v3.3.2 to v3.3.3.SummaryDifference1%

- Check92 days agoChange DetectedRevision updated from v3.2.0 to v3.3.2 on the page.SummaryDifference0.0%

Stay in the know with updates to Enapotamab Vedotin Safety Study in Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Enapotamab Vedotin Safety Study in Solid Tumors Clinical Trial page.